The brain injury in the premature born infant: stem cell regeneration research network, PREMSTEM, is a collective of world leading clinicians, researchers, stakeholder advocacy groups and an industrial partner with well-established experience in neonatology and drug development.
PREMSTEM is focused on delivering to the clinic a novel regenerative therapy to reduce the enormous emotional, health and economic implications of neurodevelopmental injury caused by encephalopathy of prematurity (EoP) – brain damage associated with premature birth (i.e. before 37 of 40 weeks of gestation).
Advances in perinatal medicine, especially in respiratory support mean that even the sickest and smallest babies with EoP often survive, but there are currently no treatments to repair the brain damage of EoP.
Read more about PREMSTEM on their website / The text above is taken from their website